We are live on ! Find out more
MVP

Miller Value Partners Portfolio holdings

AUM $423M
1-Year Est. Return 49.14%
This Fund
S&P 500
This Quarter Est. Return
+4.8%
1 Year Est. Return
+49.14%
3 Year Est. Return
+132.73%
5 Year Est. Return
+100.12%
10 Year Est. Return
+859.21%
AUM
$2.63B
AUM Growth
+$104M
Cap. Flow
-$31.6M
Cap. Flow %
-1.2%
Top 10 Hldgs %
37.7%
Holding
117
New
15
Increased
33
Reduced
29
Closed
15
Avg Time Held Equity + Options
7.8 quarters
Top 10 Avg Time Held Equity + Options
4.4 quarters
Top 20 Avg Time Held Equity + Options
7.7 quarters
Avg Time Held Equity only
8.2 quarters
Top 10 Avg Time Held Equity only
4.4 quarters
Top 20 Avg Time Held Equity only
8 quarters

Top Buys

Rank Stock Value
1
TVTY
Tivity Health, Inc. Common Stock
TVTY
+$52M
2
CVS icon
CVS Health
CVS
+$40.9M
3
BABA icon
Alibaba
BABA
+$39.1M
4
ADT icon
ADT
ADT
+$30.9M
5
EB icon
Eventbrite
EB
+$30.8M

Sector Composition

Rank Sector Weight
1 Healthcare 21.76%
2 Financials 19.36%
3 Consumer Discretionary 18.02%
4 Industrials 11.94%
5 Communication Services 10.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
AMZN icon
1
Amazon
AMZN
$2.8T
$136M 5.18%
1,436,820
-97,900
-6% -$9.12M
2013 Q2
24 quarters
BHC icon
2
Bausch Health
BHC
$2.22B
$117M 4.46%
4,648,989
-124,160
-3% -$2.95M
2016 Q1
13 quarters
RH icon
3
RH
RH
$2.21B
$107M 4.07%
924,910
+2,700
+0.3% +$279K
2016 Q4
10 quarters
OMF icon
4
OneMain Financial
OMF
$6.44B
$103M 3.94%
3,060,130
-116,630
-4% -$3.81M
2013 Q4
22 quarters
ENDP
5
CALL
DELISTED
Endo International plc
ENDP
$101M 3.84%
+200,412
New +$1.27M
2019 Q2
0 quarters
ADT icon
6
ADT
ADT
$4.71B
$99.1M 3.77%
16,193,975
+4,855,385
+43% +$30.9M
2018 Q2
4 quarters
META icon
7
Meta Platforms (Facebook)
META
$1.89T
$86.5M 3.29%
448,315
+310
+0.1% +$56.6K
2017 Q2
8 quarters
BHF icon
8
Brighthouse Financial
BHF
$2.78B
$84.1M 3.2%
2,291,455
+4,900
+0.2% +$189K
2018 Q2
4 quarters
JPM icon
9
JPMorgan Chase
JPM
$889B
$78.9M 3%
706,025
-61,370
-8% -$6.77M
2018 Q3
3 quarters
AVP
10
DELISTED
Avon Products, Inc.
AVP
$77.8M 2.96%
20,053,838
-8,016,250
-29% -$26.7M
2017 Q2
8 quarters
QUOT
11
DELISTED
Quotient Technology Inc
QUOT
$77.6M 2.95%
7,228,875
+82,125
+1% +$833K
2014 Q1
21 quarters
GNW icon
12
Genworth Financial
GNW
$3.42B
$76.7M 2.92%
20,668,000
+134,500
+0.7% +$477K
2013 Q2
24 quarters
NXPI icon
13
NXP Semiconductors
NXPI
$56.8B
$74.7M 2.84%
765,595
-89,225
-10% -$8.65M
2018 Q3
3 quarters
DAL icon
14
Delta Air Lines
DAL
$52.7B
$73.4M 2.79%
1,293,780
-130,325
-9% -$7.3M
2013 Q2
24 quarters
MU icon
15
Micron Technology
MU
$1.12T
$72.7M 2.77%
1,885,015
+4,700
+0.2% +$179K
2018 Q1
5 quarters
LEN icon
16
Lennar Class A
LEN
$17.8B
$72.2M 2.75%
1,538,111
– –
2013 Q2
24 quarters
UAL icon
17
United Airlines
UAL
$33.9B
$66.6M 2.54%
761,260
-63,390
-8% -$5.36M
2013 Q2
24 quarters
BAC icon
18
Bank of America
BAC
$382B
$63M 2.4%
2,171,909
+4,115
+0.2% +$119K
2013 Q2
24 quarters
PGEN icon
19
Precigen
PGEN
$2.74B
$61.7M 2.35%
8,048,660
+964,175
+14% +$5.19M
2013 Q4
22 quarters
PHM icon
20
Pultegroup
PHM
$21.2B
$60.4M 2.3%
1,909,470
-362,505
-16% -$11.3M
2013 Q2
24 quarters
TEVA icon
21
Teva Pharmaceutical Industries Limited
TEVA
$48B
$60M 2.28%
6,500,252
+1,957,720
+43% +$23.6M
2017 Q4
6 quarters
FLXN icon
22
DELISTED
Flexion Therapeutics, Inc.
FLXN
$59.7M 2.27%
4,852,460
+742,740
+18% +$8.57M
2017 Q2
8 quarters
ALXN
23
DELISTED
Alexion Pharmaceuticals
ALXN
$58.8M 2.24%
448,780
+1,100
+0.2% +$142K
2016 Q4
10 quarters
TCRT icon
24
Alaunos Therapeutics
TCRT
$2.67M
$53.9M 2.05%
61,594
– –
2015 Q1
17 quarters
WBD icon
25
DELISTED
Warner Bros
WBD
$50.9M 1.94%
1,657,800
-249,025
-13% -$7.24M
2017 Q4
6 quarters

Similar funds

Miller Value Partners's Q2 2019 Portfolio in Review

As of Q2 2019, Miller Value Partners held 117 positions worth $2.63B, up 4.1% from $2.52B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Miller Value Partners's Q2 2019 filing shows 15 new, 33 increased, 29 reduced and 15 closed positions. Its largest new stake was Tivity Health, Inc. Common Stock: 2,693,150 shares worth $44.3M. The largest sale was Lumen Technologies, Inc. Common Stock, an estimated $42.2M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 24% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Miller Value Partners's largest Q2 2019 buy was Tivity Health, Inc. Common Stock: 2,693,150 shares worth $44.3M.
  • Miller Value Partners added most to Alibaba in Q2 2019, an estimated $39.1M increase.
  • Miller Value Partners's biggest Q2 2019 reduction was Lumen Technologies, Inc. Common Stock, cutting an estimated $42.2M.
  • Miller Value Partners fully exited Allergan plc in Q2 2019, selling an estimated $40.8M.
  • Miller Value Partners's ten largest holdings make up 38% of its $2.63B portfolio in Q2 2019.
  • Miller Value Partners opened 15 new positions and closed 15 in Q2 2019.
  • Miller Value Partners's portfolio value rose 4.1% quarter-over-quarter to $2.63B.

Based on Miller Value Partners's 13F filing for Q2 2019, filed 14 Aug 2019.